☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
BiomX
BiomX Report the Completion of Patient Dosing in Part 2 of the P-Ib/IIa Study for BX004 to Treat Chronic Pulmonary Infections in P...
October 5, 2023
Boehringer Ingelheim Collaborates with BiomX to Discover Microbiome-Based Biomarkers for Inflammatory Bowel Disease
September 3, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.